Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16709-25-4

Post Buying Request

16709-25-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16709-25-4 Usage

Chemical Properties

Colourless solid

Uses

Different sources of media describe the Uses of 16709-25-4 differently. You can refer to the following data:
1. A therapeutic and carrier molecule
2. A therapeutic and carrier molecule.

Check Digit Verification of cas no

The CAS Registry Mumber 16709-25-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,0 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 16709-25:
(7*1)+(6*6)+(5*7)+(4*0)+(3*9)+(2*2)+(1*5)=114
114 % 10 = 4
So 16709-25-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H14N2O2/c1-12(13,11(15)16)6-8-7-14-10-5-3-2-4-9(8)10/h2-5,7,14H,6,13H2,1H3,(H,15,16)/t12-/m0/s1

16709-25-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name α-Methyl-L-tryptophan

1.2 Other means of identification

Product number -
Other names (2S)-2-amino-3-(1H-indol-3-yl)-2-methylpropanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16709-25-4 SDS

16709-25-4Synthetic route

methyl 2-(indol-3-ylmethyl)-2-aminopropionate
114524-80-0

methyl 2-(indol-3-ylmethyl)-2-aminopropionate

A

α-methyl-DL-tryptophan
56452-52-9

α-methyl-DL-tryptophan

B

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

C

α-methyl-(R)-tryptophan methyl ester
96551-27-8

α-methyl-(R)-tryptophan methyl ester

Conditions
ConditionsYield
With α-chymotrypsin In water at 37℃; for 40h; pH=5.0;A 4%
B n/a
C 88%
With α-chymotrypsin In water at 37℃; for 40h; pH=5.0;A 4%
B n/a
C n/a
methyl 2-(indol-3-ylmethyl)-2-aminopropionate
114524-80-0

methyl 2-(indol-3-ylmethyl)-2-aminopropionate

A

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

B

α-methyl-(R)-tryptophan methyl ester
96551-27-8

α-methyl-(R)-tryptophan methyl ester

Conditions
ConditionsYield
With α-chymotrypsin In water at 37℃; for 40h; Product distribution; also other α-methyl-amino acid esters investigated;A n/a
B 88%
(S)-N2-benzoyl-2-methyltryptophan-methylester
116139-87-8

(S)-N2-benzoyl-2-methyltryptophan-methylester

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
With hydrogenchloride In methanol Heating;87%
tert-butyl 3-{[(3S,5aR,6aS,7aS)-2,3,5,5a,6,6a,7,7a-octahydro-3,6,6,7a-tetramethyl-2-oxobicyclo[4.1.0]hept-1(6)eno[3,4-b][1,4]oxazin-3-yl]methyl}-1H-indole-1-carboxylate
1266681-04-2

tert-butyl 3-{[(3S,5aR,6aS,7aS)-2,3,5,5a,6,6a,7,7a-octahydro-3,6,6,7a-tetramethyl-2-oxobicyclo[4.1.0]hept-1(6)eno[3,4-b][1,4]oxazin-3-yl]methyl}-1H-indole-1-carboxylate

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Stage #1: tert-butyl 3-{[(3S,5aR,6aS,7aS)-2,3,5,5a,6,6a,7,7a-octahydro-3,6,6,7a-tetramethyl-2-oxobicyclo[4.1.0]hept-1(6)eno[3,4-b][1,4]oxazin-3-yl]methyl}-1H-indole-1-carboxylate With cesium hydroxide; water In ethanol at 70℃; for 4h;
Stage #2: With hydrogenchloride In water
86%
tert-butyl [3-(3S,6R)-N-1-(tert-butoxycarbonyl)-6-isopropyl-3-methyl-2-oxo-5-phenyl-1,2,3,6-tetrahydropyrazinylmethyl]-1H-1-indolecarboxylate

tert-butyl [3-(3S,6R)-N-1-(tert-butoxycarbonyl)-6-isopropyl-3-methyl-2-oxo-5-phenyl-1,2,3,6-tetrahydropyrazinylmethyl]-1H-1-indolecarboxylate

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
With hydrogenchloride at 150℃; for 72h; Hydrolysis;40%
2-Amino-3-(1H-indol-3-yl)-2-methyl-propionic acid butyl ester
141784-94-3

2-Amino-3-(1H-indol-3-yl)-2-methyl-propionic acid butyl ester

A

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

B

(R)-2-Amino-3-(1H-indol-3-yl)-2-methyl-propionic acid butyl ester
141784-97-6

(R)-2-Amino-3-(1H-indol-3-yl)-2-methyl-propionic acid butyl ester

C

(S)-2-Amino-3-(1H-indol-3-yl)-2-methyl-propionic acid butyl ester
141784-94-3, 141784-97-6

(S)-2-Amino-3-(1H-indol-3-yl)-2-methyl-propionic acid butyl ester

Conditions
ConditionsYield
In various solvent(s) Ambient temperature; Candida lipolythica lipase (active component: Candida lypolythica esterase); Yield given. Yields of byproduct given;
In various solvent(s) Ambient temperature; Candida lipolythica lipase (active component: Candida lypolythica esterase); Yield given. Yields of byproduct given. Title compound not separated from byproducts;
2-(2-Chloro-acetylamino)-3-(1H-indol-3-yl)-2-methyl-propionic acid
121704-33-4

2-(2-Chloro-acetylamino)-3-(1H-indol-3-yl)-2-methyl-propionic acid

A

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

B

(R)-2-(2-Chloro-acetylamino)-3-(1H-indol-3-yl)-2-methyl-propionic acid
121704-33-4

(R)-2-(2-Chloro-acetylamino)-3-(1H-indol-3-yl)-2-methyl-propionic acid

Conditions
ConditionsYield
With potassium hydroxide; potassium phosphate buffer; porcine kidney acylase I at 40℃; relative initial rate of hydrolysis, also with Aspergillus acylase I as a catalyst; with or without CoCl2;
(R)-Nα-(Methoxycarbonyl)-α-methyltryptophan methyl ester

(R)-Nα-(Methoxycarbonyl)-α-methyltryptophan methyl ester

A

α-methyl-DL-tryptophan
56452-52-9

α-methyl-DL-tryptophan

B

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
With hydrogenchloride for 16h; Heating; Yield given. Yields of byproduct given. Title compound not separated from byproducts;
3-((S)-2-Benzyloxycarbonyl-2-benzyloxycarbonylamino-propyl)-indole-1-carboxylic acid benzyl ester

3-((S)-2-Benzyloxycarbonyl-2-benzyloxycarbonylamino-propyl)-indole-1-carboxylic acid benzyl ester

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol for 3h; Ambient temperature; Yield given;
DL-α-methyltryptophan
153-91-3

DL-α-methyltryptophan

A

α-methyl-DL-tryptophan
56452-52-9

α-methyl-DL-tryptophan

B

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
resolution of racemate via chiral HPLC;
With Merck RP-18 WF254S plates coated with Nτ-n-decyl-L-spinacine and Cu acetate In water; acetonitrile Resolution of racemate;
(S)-benzyl 2-(((benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanoate
69876-37-5

(S)-benzyl 2-(((benzyloxy)carbonyl)amino)-3-(1H-indol-3-yl)propanoate

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: CF3COOH / 96 h / Ambient temperature
2: Na2CO3 / dioxane; H2O / 0 °C
3: 1.) lithium bis(trimethylsilyl)amide / 1.) THF, -78 deg C, 1 h, 2.) THF, a) -78 deg C, 1 h, b) from -78 deg C to RT, 2 h
4: trifluoroacetic acid / 1.5 h / Ambient temperature
5: H2 / 10percent Pd/C / ethanol / 3 h / Ambient temperature
View Scheme
dibenzyl (2S,3aR,8aR)-3,3a,8,8a-tetrahydropyrrolo[2,3-b]indol-1,2 (2H)-dicarboxylate

dibenzyl (2S,3aR,8aR)-3,3a,8,8a-tetrahydropyrrolo[2,3-b]indol-1,2 (2H)-dicarboxylate

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Na2CO3 / dioxane; H2O / 0 °C
2: 1.) lithium bis(trimethylsilyl)amide / 1.) THF, -78 deg C, 1 h, 2.) THF, a) -78 deg C, 1 h, b) from -78 deg C to RT, 2 h
3: trifluoroacetic acid / 1.5 h / Ambient temperature
4: H2 / 10percent Pd/C / ethanol / 3 h / Ambient temperature
View Scheme
(2S,3aR,8aS)-2,3,3a,8a-Tetrahydro-pyrrolo[2,3-b]indole-1,2,8-tricarboxylic acid tribenzyl ester
200716-93-4

(2S,3aR,8aS)-2,3,3a,8a-Tetrahydro-pyrrolo[2,3-b]indole-1,2,8-tricarboxylic acid tribenzyl ester

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) lithium bis(trimethylsilyl)amide / 1.) THF, -78 deg C, 1 h, 2.) THF, a) -78 deg C, 1 h, b) from -78 deg C to RT, 2 h
2: trifluoroacetic acid / 1.5 h / Ambient temperature
3: H2 / 10percent Pd/C / ethanol / 3 h / Ambient temperature
View Scheme
(2S,3aR,8aR)-2-Methyl-2,3,3a,8a-tetrahydro-pyrrolo[2,3-b]indole-1,2,8-tricarboxylic acid tribenzyl ester
200716-94-5

(2S,3aR,8aR)-2-Methyl-2,3,3a,8a-tetrahydro-pyrrolo[2,3-b]indole-1,2,8-tricarboxylic acid tribenzyl ester

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: trifluoroacetic acid / 1.5 h / Ambient temperature
2: H2 / 10percent Pd/C / ethanol / 3 h / Ambient temperature
View Scheme
N-carbobenzyloxy-L-tryptophane
7432-21-5

N-carbobenzyloxy-L-tryptophane

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: Cs2CO3 / dimethylformamide
2: CF3COOH / 96 h / Ambient temperature
3: Na2CO3 / dioxane; H2O / 0 °C
4: 1.) lithium bis(trimethylsilyl)amide / 1.) THF, -78 deg C, 1 h, 2.) THF, a) -78 deg C, 1 h, b) from -78 deg C to RT, 2 h
5: trifluoroacetic acid / 1.5 h / Ambient temperature
6: H2 / 10percent Pd/C / ethanol / 3 h / Ambient temperature
View Scheme
(2R,4R)-2-(tert-Butyl)-3-(ethoxycarbonyl)-4-(indol-3-yl-methyl)-4-methyl-1,3-oxazolidin-5-one
170458-97-6

(2R,4R)-2-(tert-Butyl)-3-(ethoxycarbonyl)-4-(indol-3-yl-methyl)-4-methyl-1,3-oxazolidin-5-one

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 95.7 percent / LiOH*H2O / 6 h / 40 °C
2: aq. 6 N HCl / 16 h / Heating
View Scheme
(4R)-2-(tert-Butyl)-3-(ethoxycarbonyl)-4-(indol-3-yl-methyl)-1,3-oxa4olidin-5-one

(4R)-2-(tert-Butyl)-3-(ethoxycarbonyl)-4-(indol-3-yl-methyl)-1,3-oxa4olidin-5-one

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 78.9 percent / LDA / tetrahydrofuran / 1.) -78 deg C, 0.5 h, 2.) -78 deg C, 2 h
2: 95.7 percent / LiOH*H2O / 6 h / 40 °C
3: aq. 6 N HCl / 16 h / Heating
View Scheme
1-(t-butyloxycarbonyl)-3-(bromomethyl)indole
96551-21-2

1-(t-butyloxycarbonyl)-3-(bromomethyl)indole

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) HMPT, LDA / 1.) THF, -78 deg C, 40 min, 2.) THF, -78 deg C, 36 h
2: 59 percent / 1N MeONa / methanol / 24 h / Ambient temperature
3: 87 percent / 6N HCl / methanol / Heating
View Scheme
(2R,5S)-3-benzoyl-2-(tert-butyl)-4-(<1-(tert-butyloxycarbonyl)-1H-indol-3-yl>methyl)-4-methyl-5-oxazolidinon
116139-85-6

(2R,5S)-3-benzoyl-2-(tert-butyl)-4-(<1-(tert-butyloxycarbonyl)-1H-indol-3-yl>methyl)-4-methyl-5-oxazolidinon

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 59 percent / 1N MeONa / methanol / 24 h / Ambient temperature
2: 87 percent / 6N HCl / methanol / Heating
View Scheme
methanol
67-56-1

methanol

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

L-α-methyl-tryptophan methyl ester
142854-50-0

L-α-methyl-tryptophan methyl ester

Conditions
ConditionsYield
With thionyl chloride Yield given. Multistep reaction;
2-adamantyloxychloroformate

2-adamantyloxychloroformate

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

2-[(Adamantan-2-yl-oxy)-carbonyl]-amino-3-(1H-indol-3-yl)-2RS-methyl-propionic acid
130406-42-7

2-[(Adamantan-2-yl-oxy)-carbonyl]-amino-3-(1H-indol-3-yl)-2RS-methyl-propionic acid

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane
1-aminomethyl-1-(5-hydroxypyridin-2-yl)cyclohexane hydrobromide

1-aminomethyl-1-(5-hydroxypyridin-2-yl)cyclohexane hydrobromide

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(5-hydroxypyridin-2-yl)cyclohexylmethyl]-2-methylpropionamide

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(5-hydroxypyridin-2-yl)cyclohexylmethyl]-2-methylpropionamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In tetrahydrofuran at 20℃;
1-aminomethyl-1-(4-(2-fluoroethoxy)phenyl)cycloexane hydrochloride

1-aminomethyl-1-(4-(2-fluoroethoxy)phenyl)cycloexane hydrochloride

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(4-(2-fluoroethoxy)phenyl)cyclohexylmethyl]-2-methylpropionamide

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(4-(2-fluoroethoxy)phenyl)cyclohexylmethyl]-2-methylpropionamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In tetrahydrofuran at 20℃;
1-aminomethyl-1-(2-fluoropyridin-4-yl)cycloexane

1-aminomethyl-1-(2-fluoropyridin-4-yl)cycloexane

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(2-fluoropyridin-5-yl)-cyclohexylmethyl]-2-methylpropionamide

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(2-fluoropyridin-5-yl)-cyclohexylmethyl]-2-methylpropionamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In tetrahydrofuran at 20℃;
1-aminomethyl-1-(2-fluoropyridin-5-yl)cycloexane

1-aminomethyl-1-(2-fluoropyridin-5-yl)cycloexane

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(2-fluoropyridin-5-yl)-cyclohexylmethyl]-2-methylpropionamide

(S)-2-amino-3-(1H-indol-3-yl)-N-[1-(2-fluoropyridin-5-yl)-cyclohexylmethyl]-2-methylpropionamide

Conditions
ConditionsYield
With 4-methyl-morpholine; benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate In tetrahydrofuran at 20℃;
1-aminomethyl-1-(2-fluoropyridin-5-yl)cycloexane

1-aminomethyl-1-(2-fluoropyridin-5-yl)cycloexane

(S)-α-methyltryptophan
16709-25-4

(S)-α-methyltryptophan

(S)-3-(1H-indol-3-yl)-N-[1-(2-fluoropyrid-5-yl)cyclohexylmethyl]-2-methyl-2-[3-(4-nitrophenyl)ureido]propionamide

(S)-3-(1H-indol-3-yl)-N-[1-(2-fluoropyrid-5-yl)cyclohexylmethyl]-2-methyl-2-[3-(4-nitrophenyl)ureido]propionamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 4-methyl-morpholine; benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate / tetrahydrofuran / 20 °C
2: tetrahydrofuran / 24 h / 20 °C
View Scheme

16709-25-4Relevant articles and documents

Chiral ligand-exchange resolution of underivatized amino acids on a dynamically modified stationary phase for RP-HPTLC

Remelli, Maurizio,Faccini, Stefania,Conato, Chiara

, p. 313 - 318 (2014/06/09)

The synthesis of Spi(τ-dec), derived from the selective alkylation of L-spinacine (4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid) at the τ-nitrogen of its heteroaromatic ring, with a linear hydrocarbon chain of 10 carbon atoms, is described here for the first time. Spi(τ-dec) was successfully employed in the past to prepare home-made chiral columns for chiral ligand-exchange high-performance liquid chromatography. In the present article a new method is described, using Spi(τ-dec) as a chiral selector in high-performance thin-layer chromatography (HPTLC): commercial hydrophobic plates were first coated with Spi(τ-dec) and then treated with copper sulfate. The performance of this new chiral stationary phase was tested against racemic mixtures of aromatic amino acids, after appropriate optimization of both the conditions of preparation of the plates and the mobile phase composition. The enantioselectivity values obtained for the studied compounds were higher than those reported in the literature for similar systems. The method employed here for the preparation of chiral HPTLC plates proved practical, efficient, and inexpensive. Chirality 26:313-318, 2014. 2014 Wiley Periodicals, Inc.

Asymmetric synthesis of α-Methyl α-Amino Acids through diastereoselective alkylation under mild reaction conditions of an iminic alanine template with a 1,2,3,6-Tetrahydro-2-Pyrazinone structure

Najera, Carmen,Abellan, Tomas,Sansano, Jose M.

, p. 2809 - 2820 (2007/10/03)

(6R)-6-Isopropyl-3-methyl-5-phenyl-1,2,3,6-tetrahydro-2-pyrazinone, obtained from (R)-valine and (S)-alanine, is highly diastereoselectively alkylated at room temperature by: a) activated alkyl halides under solid-liquid PTC conditions, b) non-activated alkyl halides with organic bases, c) electrophilic olefins employing both solid-liquid PTC conditions and organic bases, and d) allylic carbonates by means of palladium catalysis under neutral conditions. Enantiomerically pure (S)-α-methyl α-amino acids 8 are obtained by hydrolysis of the alkylated pyrazinones.

Pharmacokinetics of α-methyl-L-tryptophan in rhesus monkeys and calculation of the lumped constant for estimating the rate of serotonin synthesis

Shoaf, Susan E.,Schmall, Bernard

, p. 219 - 224 (2007/10/03)

We have determined several kinetic and pharmacokinetic parameters of L- tryptophan (Trp) and α-methyl-L-tryptophan (αMTrp) in the rhesus monkey from which the lumped constant for the αMTrp method of estimating serotonin synthesis rates is calculated. αMTrp was isolated from DL-αMTrp using a chiral separation column with high performance liquid chromatography. αMTrp (50 μg/kg) was administered i.v. to four adult male rhesus monkeys and arterial blood samples were collected for a 4-hr period. Plasma concentrations, as determined by high performance liquid chromatography with electrochemical detection, were best fitted by a tri-exponential equation. Plasma protein binding of Trp and αMTrp was determined by measuring concentrations in ultrafiltrates obtained at 30°C. After a 2-hr adjusted rate infusion of αMTrp designed to establish steady-state plasma concentrations, three adult male rhesus monkeys were killed by exsanguination with perfused ice-cold saline. Brain/arterial plasma concentration ratios of Trp and αMTrp and the Michaelis-Menten parameters for tryptophan hydroxylase, EC 1.14.16.4, with Trp and αMTrp as initiating substrates, were determined for seven brain regions. The lumped constants determined for the different brain regions were not significantly different from each other and indicate, that for modeling purposes, the brain may be treated as a homogeneous area and the lumped constant given a single value, 0.18 ± 0.05.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16709-25-4